150 related articles for article (PubMed ID: 8327864)
1. [In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
Heininger K
Schriftenr Neurol; 1993; 33():1-91. PubMed ID: 8327864
[No Abstract] [Full Text] [Related]
2. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
3. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
4. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
5. [Immunoadsorption--a new treatment of myasthenia gravis].
Berning T; Krummenerl T; Glaser J; Paulus H; van Husen N
Med Klin (Munich); 1988 Feb; 83(4):125-8. PubMed ID: 3285161
[No Abstract] [Full Text] [Related]
6. Semi-selective immunoadsorption treatment in myasthenia gravis.
Splendiani G; Passalacqua S; Barbera G; Sturniolo G; Costanzi S; Fulignati P; Casciani CU
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(5):1145-51. PubMed ID: 1457688
[TBL] [Abstract][Full Text] [Related]
7. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
Suga M; Akahonai Y; Tsujisaki M; Mori M; Yoshizaki H; Matsumoto H; Yachi A
Hokkaido Igaku Zasshi; 1982 Nov; 57(6):734-40. PubMed ID: 7183499
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of plasma exchange in management of myasthenia gravis (author's transl)].
Arahata K; Sato T; Narabayashi H
Rinsho Shinkeigaku; 1981 Jul; 21(7):597-606. PubMed ID: 7307400
[No Abstract] [Full Text] [Related]
9. Immunoadsorption therapy for myasthenia gravis.
Shibuya N; Sato T; Osame M; Takegami T; Doi S; Kawanami S
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):578-81. PubMed ID: 8201327
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
Somnier FE; Langvad E
J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
[TBL] [Abstract][Full Text] [Related]
11. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Loschiavo C; Grecò M; Polo A; Del Colle R
G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
Huo JT; Long HL; Luo X; Xu JZ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
[TBL] [Abstract][Full Text] [Related]
13. Immunosorbent treatment in myasthenia gravis.
Passalacqua S; Splendiani G; Sturniolo A; Costanzi S; Barbera G; Bartoccioni E; Evoli A; Scoppetta C; Adorno D; Di Guilio S
Prog Clin Biol Res; 1990; 337():285-8. PubMed ID: 2191321
[No Abstract] [Full Text] [Related]
14. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
15. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
[TBL] [Abstract][Full Text] [Related]
16. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
[No Abstract] [Full Text] [Related]
17. [Determination of anti-acetylcholine receptor antibodies in myasthenia and its treatment by plasma exchange and immunosuppressants].
Goulon M; Gajdos P; Goulon C; Bussel A; Morel E; Raimond F; Estournet B
C R Seances Soc Biol Fil; 1980; 174(4):467-78. PubMed ID: 6449232
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic apheresis in myasthenia gravis.
Batocchi AP; Evoli A; Di Schino C; Tonali P
Ther Apher; 2000 Aug; 4(4):275-9. PubMed ID: 10975473
[TBL] [Abstract][Full Text] [Related]
19. Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
Baggi F; Ubiali F; Nava S; Nessi V; Andreetta F; Rigamonti A; Maggi L; Mantegazza R; Antozzi C
J Neuroimmunol; 2008 Sep; 201-202():104-10. PubMed ID: 18644634
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
